BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32692700)

  • 1. Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
    Majbour N; El-Agnaf O
    Diagnosis (Berl); 2020 Nov; 7(4):373-376. PubMed ID: 32692700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
    Farrugia A
    Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
    [No Abstract]   [Full Text] [Related]  

  • 3. "Because Every Drop Counts": Blood donation during the COVID-19 Pandemic.
    Sahu KK; Raturi M; Siddiqui AD; Cerny J
    Transfus Clin Biol; 2020 Aug; 27(3):105-108. PubMed ID: 32782213
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion.
    Xia X; Li K; Wu L; Wang Z; Zhu M; Huang B; Li J; Wang Z; Wu W; Wu M; Li W; Li L; Cai Y; Bosco B; Zhong A; Liu X; Lv T; Gan Z; Chen G; Pan Y; Liu C; Zhang K; Xu X; Wang C; Wang Q
    Blood; 2020 Aug; 136(6):755-759. PubMed ID: 32573724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The resurgence of convalescent plasma therapy.
    The Lancet Haematology
    Lancet Haematol; 2020 May; 7(5):e353. PubMed ID: 32359447
    [No Abstract]   [Full Text] [Related]  

  • 6. Deployment of convalescent plasma for the prevention and treatment of COVID-19.
    Bloch EM; Shoham S; Casadevall A; Sachais BS; Shaz B; Winters JL; van Buskirk C; Grossman BJ; Joyner M; Henderson JP; Pekosz A; Lau B; Wesolowski A; Katz L; Shan H; Auwaerter PG; Thomas D; Sullivan DJ; Paneth N; Gehrie E; Spitalnik S; Hod EA; Pollack L; Nicholson WT; Pirofski LA; Bailey JA; Tobian AA
    J Clin Invest; 2020 Jun; 130(6):2757-2765. PubMed ID: 32254064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convalescent plasma to treat COVID-19.
    Bloch EM
    Blood; 2020 Aug; 136(6):654-655. PubMed ID: 32761219
    [No Abstract]   [Full Text] [Related]  

  • 8. Convalescent Plasma: Promise for COVID-19 Pandemic.
    Sheikh S; Baig MA
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):88. PubMed ID: 32723468
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of convalescent plasma in hospitalized patients with COVID-19: case series.
    Hegerova L; Gooley TA; Sweerus KA; Maree C; Bailey N; Bailey M; Dunleavy V; Patel K; Alcorn K; Haley R; Johnsen JM; Konkle BA; Lahti AC; Alexander ML; Goldman JD; Lipke A; Lim SJ; Sullivan MD; Pauk JS; Pagel JM
    Blood; 2020 Aug; 136(6):759-762. PubMed ID: 32559767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
    Morabito CJ; Gangadharan B
    Clin Transl Sci; 2020 Sep; 13(5):835-837. PubMed ID: 32420691
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convalescent Plasma and COVID-19.
    Malani AN; Sherbeck JP; Malani PN
    JAMA; 2020 Aug; 324(5):524. PubMed ID: 32530454
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 convalescent plasma donor recruitment: beware the Faustian bargains.
    Gniadek TJ; Donnersberger D
    Transfusion; 2020 Jul; 60(7):1643-1644. PubMed ID: 32428966
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.
    Zeng QL; Yu ZJ; Gou JJ; Li GM; Ma SH; Zhang GF; Xu JH; Lin WB; Cui GL; Zhang MM; Li C; Wang ZS; Zhang ZH; Liu ZS
    J Infect Dis; 2020 Jun; 222(1):38-43. PubMed ID: 32348485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Jul; 370():m2722. PubMed ID: 32646867
    [No Abstract]   [Full Text] [Related]  

  • 16. Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.
    Li L; Yang R; Wang J; Lv Q; Ren M; Zhao L; Chen H; Xu H; Xie S; Xie J; Lin H; Li W; Fang P; Gong L; Wang L; Wu Y; Liu Z
    Transfusion; 2020 Aug; 60(8):1773-1777. PubMed ID: 32491199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of convalescent plasma in COVID-19 patients in China.
    Zhu M; Hu K; Zhu Z
    Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
    [No Abstract]   [Full Text] [Related]  

  • 18. The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq.
    Rasheed AM; Fatak DF; Hashim HA; Maulood MF; Kabah KK; Almusawi YA; Abdulamir AS
    Infez Med; 2020 Sep; 28(3):357-366. PubMed ID: 32920571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19.
    Nnaji CA; Iwu CJ; Ndwandwe DE; Jordan P; Wiysonge CS
    S Afr Med J; 2020 Jul; 110(8):759-760. PubMed ID: 32880303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors.
    Andersen KJ; Klassen SA; Larson KF; Ripoll JG; Senefeld JW; Clayburn AJ; Shepherd JRA; Tseng AS; Wiggins CC; Murphy BM; Ford SK; Johnson CP; Miller AD; Baker SE; Wright RS; Winters JL; Stubbs JR; Joyner MJ; van Buskirk CM
    Mayo Clin Proc; 2020 Nov; 95(11):2343-2349. PubMed ID: 33153626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.